FDA & Prescription Drugs

• Safety Concerns about Diabetes Drug Avandia

  David Mittleman | November 07, 2008 8:52 AM | 0 CommentsLansing, MI

  Avandia is a popular type 2 diabetes drug that was first marketed in 1999. It is one of many oral medications designed to control blood sugar. Avandia lowers the amount of sugar in your blood by...

• Avandia – Too Toxic to Be On The Market

  Beth Janicek | November 06, 2008 3:35 PM | 0 CommentsSan Antonio, TX

  Avandia (rosiglitazone maleate) prescribed to diabetics helps improve blood sugar control in adults with type 2 diabetes. On October 30th, Public Citizen petitioned the Food and Drug...

• New Pressure on FDA Regarding Avandia

  Jamie Sheller | November 05, 2008 9:18 PM | 0 CommentsPhiladelphia, PA

  Avandia, a diabetes drug made by GlaxoSmithKline, used to be a top-seller. However, its sales have sharply declined since May 2007 when a study showed a 43 percent increased risk of heart attack...

• FDA Says Bard Needs to Clean Up in Puerto Rico

  Brenda Fulmer | November 05, 2008 8:59 AM | 1 CommentWest Palm Beach, FL

  C. R. Bard, is a leader in the manufacture of surgical mesh products and other medical devices used in the areas of vascular and general surgery, urology, and oncology. Bard now faces significant...

• Coordination of Digitek Claims Nationwide Underway

  Brenda Fulmer | November 04, 2008 6:18 AM | 0 CommentsWest Palm Beach, FL

  Judge Joseph R. Goodwin, a federal judge in Charleston, West Virginia, has been selected to oversee pre-trial coordination of the Digitek litigation. Judge Goodwin will hold the first hearing to...

• PAIN PATCH LAWSUIT DECIDED BY JURY

  William Grewe | November 03, 2008 8:16 PM | 0 CommentsVentura, CA

  A Florida jury found the maker of drug patches which release pain medication (fentanyl) responsible for the wrongful death of a mother of five who was using the Duragesic patches. The 34-year-old...

• Congressional Report Shows That FDA Senior Officials Opposed Bush Administration Preemption Actions

  Mike Bryant | November 03, 2008 8:04 PM | 0 CommentsSt. Cloud, MN

  In a report released this week by the U.S. House Committee on Oversight and Government Reform evidence seems clear that senior FDA official opposed the plans of the Bush administration to rewrite...

• FDA Criticized for Stance on BPA

  David Mittleman | November 03, 2008 8:55 AM | 0 CommentsLansing, MI

  In recent months, concerns over the safety of bisphenol-A (BPA) have been heavily publicized. The potential hazards have prompted many retailers to stop selling consumer products containing the...

• Day In Court For Drug Injury Victims At Stake In FDA Preemption Case

  David Lowe | November 03, 2008 8:50 AM | 0 CommentsMilwaukee, WI

  The U.S. Supreme Court hears oral arguments today in the FDA drug labeling preemption case Wyeth v. Levine. The court will face the question whether pharmaceutical manufacturers can be held liable...

• Phenergan Causes Gangrene, & the FDA's Cool with it - a Huge Preemption Case for the Supreme Court.

  Mike Ferrara | November 03, 2008 7:08 AM | 5 CommentsCherry Hill, NJ

  This week, the US Supreme Court will begin hearing Wyeth v. Levine, the Court’s third preemption case in less than a year. At issue in the case is one woman’s horrific experience with...